Cover Image

Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans

Fexuprazan is a new drug candidate in the potassium-competitive acid blocker (P-CAB) family. As proton pump inhibitors (PPIs), P-CABs inhibit gastric acid secretion and can be used to treat gastric acid-related disorders such as gastroesophageal reflux disease (GERD). Physiologically based pharmacok...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yoo-Seong Jeong (Author), Min-Soo Kim (Author), Nora Lee (Author), Areum Lee (Author), Yoon-Jee Chae (Author), Suk-Jae Chung (Author), Kyeong-Ryoon Lee (Author)
Format:	Book
Published:	MDPI AG, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans
by: Min-Soo Kim, et al.
Published: (2022)

Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics
by: Myongjae Lee, et al.
Published: (2022)

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
by: Min-Soo Kim, et al.
Published: (2023)

Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells
by: Yoon-Jee Chae, et al.
Published: (2021)

Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males
by: Heejae Won, et al.
Published: (2024)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
by: Yoo-Kyung Song, et al.
Published: (2021)

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects
by: JungJin Oh, et al.
Published: (2023)

A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State
by: Wonsuk Shin, et al.
Published: (2023)

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
by: Kyeong-Ryoon Lee, et al.
Published: (2024)

Effects of 1α,25-Dihydroxyvitamin D<sub>3</sub> on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach
by: Anusha Balla, et al.
Published: (2021)

Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations
by: Hyeon-Cheol Jeong, et al.
Published: (2022)

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
by: Kyeong-Ryoon Lee, et al.
Published: (2022)

Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats
by: Yoo-Kyung Song, et al.
Published: (2020)

Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats
by: Yoo-Seong Jeong, et al.
Published: (2019)

Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
by: Won-ho Kang, et al.
Published: (2021)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
by: Min-Chang Kim, et al.
Published: (2022)

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine
by: Lien Thi Ngo, et al.
Published: (2022)

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation
by: Jeong-Min Lee, et al.
Published: (2024)

Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
by: Shin D, et al.
Published: (2018)

Physiologically‐based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co‐administered with ritonavir
by: Zexu Sun, et al.
Published: (2024)

A population PK-PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808
by: Tae Kyu Chung, et al.
Published: (2022)

Pharmacokinetic Evaluation of Metabolic Drug Interactions between Repaglinide and Celecoxib by a Bioanalytical HPLC Method for Their Simultaneous Determination with Fluorescence Detection
by: Dong-Gyun Han, et al.
Published: (2019)

Evaluation for Potential Drug-Drug Interaction of MT921 Using In Vitro Studies and Physiologically-Based Pharmacokinetic Models
by: Hyo-jeong Ryu, et al.
Published: (2021)

Effects of Body Weight Control Behaviors on Bone Mineral Density in Korean Young Adult Women
by: Chae Weon Chung, et al.
Published: (2013)

Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
by: Deok Yong Yoon, et al.
Published: (2021)

Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics
by: Jaeok Lee, et al.
Published: (2019)

Pharmacokinetic comparison of subcutaneously administered CT‐P13 (biosimilar of infliximab) via autoinjector and pre‐filled syringe in healthy participants
by: Ye Chan Park, et al.
Published: (2024)

Population Pharmacokinetic Model of AST-001, L-Isomer of Serine, Combining Endogenous Production and Exogenous Administration in Healthy Subjects
by: Soyoung Lee, et al.
Published: (2022)

Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and <i>O</i>-Desmethyltramadol Pharmacokinetic Profiles in a Korean Population Using Physiologically-Based Pharmacokinetic Modeling
by: Hyeon-Cheol Jeong, et al.
Published: (2019)

Pharmacokinetic Study of NADPH Oxidase Inhibitor Ewha-18278, a Pyrazole Derivative
by: Seul Gee Lee, et al.
Published: (2019)

A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases
by: Hyo-jeong Ryu, et al.
Published: (2022)

Kinetic modeling of the plasma pharmacokinetic profiles of ADAMTS13 fragment and its Fc-fusion counterpart in mice
by: Heechun Kwak, et al.
Published: (2024)

Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
by: Cheng-Yu Wang, et al.
Published: (2019)

Drug Metabolism, Pharmacokinetics and Bioanalysis
by: Lee, Hye Suk
Published: (2019)

Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
by: Chang Ho Lee, et al.
Published: (2015)

Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimens
by: Kyo Won Lee, et al.
Published: (2019)

Development of a Physiologically Based Pharmacokinetic Model for Tegoprazan: Application for the Prediction of Drug-Drug Interactions with CYP3A4 Perpetrators
by: Lien Thi Ngo, et al.
Published: (2023)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
by: Hyo-Jeong Jang, et al.
Published: (2012)

Automatic Assessment of Upper Extremity Function and Mobile Application for Self-Administered Stroke Rehabilitation
by: Dong-Wook Kim, et al.
Published: (2024)

An Experimental Study on Blood according to the administered dosage of Carthami Flos
by: Cho, Hoo-Lee, et al.
Published: (2006)